The verified answer
As of Sep 2026, DEPLOY verifies Microsure: 1 model, 2 deployments across 1 region, $42.0M raised. 2 sources back the record.
CategorySurgical robots
Overview
Microsure is an Eindhoven-based medical robotics company developing high-precision robot-assisted systems for microsurgery. Its MUSA-3 system downscales and stabilizes surgeon hand movements for super-microsurgical procedures on lymphatic ducts, blood vessels, and nerves. CE mark approved May 2026. Raised €38M for clinical studies and FDA clearance pathway.
Verified record
- Verified deployments
- 2 deployments on file
- Active incidents
- None on file
Valuation of record
DEPLOY VERIFIEDPriced roundOther post-money
Key facts
Headquarters
Status
Type
Data & sources
Press releases
1
Web sources
1
2 sources backing this record.View all →
Models (1)
View all models →Microsure on the deployment map
View the global map2 verified deployments across 1 region, newest verified Jun 2024. Explore where Microsure's robots are operating, by place and type.
View the full Microsure deployment record →
Relationships
Current leadership (2)
- Alex Joseph CEOsecondary-verified
- Alex Joseph CEOreported, not verified
Safety record
No incidents on record for Microsure.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- Microsure2 deployments
Recent coverage
Microsure in third-party press
Peers
41 peers across 1 segment. Every Microsure competitor derived from shared form-factor and application-domain edges.
surgical robot(41)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Butterfly Networkdirect competitor(inferred)strong
- Cornerstone Roboticsdirect competitor(inferred)strong
- Edge Medical Roboticsdirect competitor(inferred)strong
- ForSight Roboticsdirect competitor(inferred)strong
- LDR Holding Corporationdirect competitor(inferred)strong
- LEM Surgicaldirect competitor(inferred)strong
Financial state
- Total funding
- $42.0M
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- growth
- Counterparty risk class
- unknown
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Funding rounds (1)
- Other2024-01-01
$42M(reported) · $210M post
Timeline
Every recorded move in Microsure’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
Funding roundOther funding round
2024-01-01Other raising $42000000
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdAug 8, 2026
Added to the verified registry
- Deployment verifiedVerifiedJun 1, 2024
Microsure MUSA-3 at Netherlands, Europe
- Deployment verifiedVerifiedJun 1, 2024
Microsure MUSA-3 at Germany, Europe
Sources (2)
Common questions
What is Microsure?
What does Microsure make?
Is Microsure publicly traded?
Who competes with Microsure?
Who is the CEO of Microsure?
How can I invest in Microsure?
Where is Microsure headquartered?
How much funding has Microsure raised?
Who owns Microsure?
Where does Microsure operate robots?
How many robots has Microsure deployed?
Is Microsure a top robotics company?
Is Microsure safe?
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-08-21
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Microsure.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning Microsure from third-party publications. Automatically surfaced; not part of the verified registry record.
Machine-readable surfaces
- Markdown mirror: /companies/microsure.md
- RSS feed: /companies/microsure/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/380919b3-4c0a-4c82-899b-74747251e6c9
- Revision history: /companies/microsure/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
World's first robot for microsurgery. Developed by surgeons, for surgeons.
dr. Tom van Mulken explains the medical need of robotic microsurgery. MUSA-3 is the newest microsurgical robot, still in development. Not for sale (yet). Plea
MUSA-3 is the newest microsurgical robot, still in development. Not for sale (yet). Please visit our webiste: www.microsure.nl for more information.
In this episode of MicroMasters, we sit down with Prof. Dr. Jesse Selber, Professor of Plastic Surgery and a global pioneer in robotic innovation, to explore ho
In MedTech, regulatory uncertainty is one of the biggest business risks — especially under investor pressure. Start-ups like Microsure are expected to deliver
In this short demonstration, we show how to securely mount a microsurgical instrument onto the MUSA‑3 robotic arm using a disposable adapter. This design allow
We’re proud to kick off our MicroMasters series, a spotlight on the surgeons pioneering the future of microsurgery. In this premiere episode, we speak with Dr
In this episode of the MicroMasters series, we speak with Dr. Tom van Mulken, a leading reconstructive microsurgeon and researcher in robotic-assisted surgery.
Heat Index
Category contender75/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Microsure draws attention at the 19th percentile but verifies reality at the 37th percentile among surgical robots. Hype Gap -17.4, 34th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 2 verified deployments. Deployment footprint remains limited relative to category peers.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Sep 23, 2026